Sun Pharma arm to unveil Bempedoic Acid under brand name Brillo in India
Pharma major, Sun Pharmaceutical Industries Limited, has recently announced that one of its wholly-owned subsidiaries plans to launch a first-in-class oral drug, Bempedoic Acid, in India for reducing low-density lipoprotein (LDL) cholesterol.
The company will launch the drug under the brand name "Brillo". Brillo is a first-in-class drug which has a new mechanism of action compared to the currently available lipid-lowering agents. It is indicated for people who have an inherited genetic disorder that causes high cholesterol levels or established heart disease where cholesterol levels remain high, despite lifestyle changes and the use of maximum tolerated dose of statins.
For more details, check out the full story on the link below: